Smith and Nephew maintains growth in second quarter of 2012

Smith and Nephew has announced its second-quarter financial results for 2012, during which it experienced continued business growth.

The medical technology firm's revenue total came to $1.03 billion (658.05 million pounds), up by two percent on an underlying basis, while its trading profit rose by six percent to $234 million.

Strong performances were noted for the company's sports medicine joint repair and negative pressure wound therapy divisions, while its efforts to embrace efficient new models and innovative methods also had a positive effect.

Olivier Bohuon, the company's chief executive officer, said: "Smith and Nephew completed a good first half as we continued to generate top-line growth and delivered an improved trading profit margin."

He added that the firm has also been able to substantially improve its dividend payout, while maintaining its flexibility in meeting organic and inorganic growth objectives.

Last month, the company expanded its product range with the launch of Allevyn Life, an innovative new wound management dressing.